Early life adversity as a risk factor for cognitive impairment and Alzheimer's disease

被引:29
|
作者
Huang, Zhihai [1 ]
Jordan, J. Dedrick [1 ]
Zhang, Quanguang [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, 1501 Kings Highway, Shreveport, LA 71103 USA
基金
美国国家卫生研究院;
关键词
Early life adversity; Cognitive impairment; Alzheimer's disease; Dementia; Stress; ADULT HIPPOCAMPAL NEUROGENESIS; LONG-LASTING CONSEQUENCES; PITUITARY-ADRENAL AXIS; MATERNAL SEPARATION; MOUSE MODEL; HPA AXIS; CHILDHOOD EXPERIENCES; PREFRONTAL CORTEX; AMYLOID-BETA; STRESS;
D O I
10.1186/s40035-023-00355-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurological conditions, including cognitive impairment and Alzheimer's disease (AD), impose a huge burden on society, affecting millions of people globally. In addition to genetic factors, recent studies indicate that environmental and experiential factors may contribute to the pathogenesis of these diseases. Early life adversity (ELA) has a profound impact on brain function and health later in life. In rodent models, exposure to ELA results in specific cognitive deficits and aggravated AD pathology. Extensive concerns have been raised regarding the higher risk of developing cognitive impairments in people with a history of ELA. In this review, we scrutinize findings from human and animal studies focusing on the connection of ELA with cognitive impairment and AD. These discoveries suggest that ELA, especially at early postnatal stages, increases susceptibility to cognitive impairment and AD later in life. In terms of mechanisms, ELA could lead to dysregulation of the hypothalamus-pituitary-adrenal axis, altered gut microbiome, persistent inflammation, oligodendrocyte dysfunction, hypomyelination, and aberrant adult hippocampal neurogenesis. Crosstalks among these events may synergistically contribute to cognitive impairment later in life. Additionally, we discuss several interventions that may alleviate adverse consequences of ELA. Further investigation into this crucial area will help improve ELA management and reduce the burden of related neurological conditions.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Early life adversity as a risk factor for cognitive impairment and Alzheimer’s disease
    Zhihai Huang
    J. Dedrick Jordan
    Quanguang Zhang
    Translational Neurodegeneration, 12
  • [2] Late-Life Depression as a Risk Factor for Mild Cognitive Impairment or Alzheimer's Disease in 30 US Alzheimer's Disease Centers
    Steenland, Kyle
    Karnes, Conny
    Seals, Ryan
    Carnevale, Claudine
    Hermida, Adriana
    Levey, Allan
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (02) : 265 - 275
  • [3] Mild TBI in the elderly - risk factor for rapid cognitive impairment in Alzheimer's disease
    Stovicek, Puiu Olivian
    Friedmann, Carol
    Marinescu, Dragos
    Vaduva, Ion Alexandru
    Bondari, Simona
    Trifu, Simona Corina
    Marinescu, Ileana
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2020, 61 (01): : 61 - 72
  • [4] Mild cognitive impairment -: an early stage of Alzheimer's disease?
    Almkvist, O
    Basun, H
    Bäckman, L
    Herlitz, A
    Lannfelt, L
    Small, B
    Viitanen, M
    Wahlund, LO
    Winblad, B
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (54): : 21 - 29
  • [5] Mild cognitive impairment as an early indicator of Alzheimer's disease
    Petersen, RC
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 562 - 562
  • [6] Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer's Disease Risk Factor APOE
    Fernandez, Harvey R.
    Varma, Ashima
    Flowers, Sarah A.
    Rebeck, George William
    CANCERS, 2020, 12 (12) : 1 - 25
  • [7] Cognitive stimulation in mild cognitive impairment and early stage Alzheimer's disease
    Rigaud, AS
    de Rotrou, J
    Cantegreil, I
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S124 - S124
  • [8] Quality of life in mild cognitive impairment and mild Alzheimer's disease
    Shin, I. S.
    Kim, J. M.
    Kim, S. W.
    Yoon, J. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S382 - S383
  • [9] Imaging and Biomarkers in Early Alzheimer's Disease and Mild Cognitive Impairment
    Petersen, R. C.
    Jack, C. R., Jr.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 438 - 441
  • [10] Rates of progression in mild cognitive impairment and early Alzheimer's disease
    Storandt, M
    Grant, EA
    Miller, JP
    Morris, JC
    NEUROLOGY, 2002, 59 (07) : 1034 - 1041